A detailed history of Tompkins Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Tompkins Financial Corp holds 2,500 shares of AZN stock, worth $163,375. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$163,375
Previous $194,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$66.81 - $80.83 $167,025 - $202,075
2,500 New
2,500 $194,000
Q2 2022

Jul 14, 2022

SELL
$59.26 - $71.14 $7,881 - $9,461
-133 Reduced 41.05%
191 $13,000
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $363,511 - $434,685
-7,492 Reduced 95.85%
324 $16,000
Q4 2020

Feb 05, 2021

BUY
$48.52 - $58.02 $363,511 - $434,685
7,492 Added 2312.35%
7,816 $349,000
Q1 2020

Apr 22, 2020

SELL
$37.79 - $51.33 $30,458 - $41,371
-806 Reduced 71.33%
324 $14,000
Q4 2019

Jan 22, 2020

SELL
$42.46 - $50.46 $6,708 - $7,972
-158 Reduced 12.27%
1,130 $56,000
Q3 2019

Oct 17, 2019

SELL
$40.12 - $45.47 $16,770 - $19,006
-418 Reduced 24.5%
1,288 $57,000
Q1 2019

Apr 30, 2019

SELL
$35.49 - $43.02 $283 - $344
-8 Reduced 0.47%
1,706 $69,000
Q1 2019

Apr 17, 2019

BUY
$35.49 - $43.02 $283 - $344
8 Added 0.47%
1,714 $68,000
Q4 2018

Jan 22, 2019

SELL
$36.86 - $41.49 $294 - $331
-8 Reduced 0.47%
1,706 $65,000
Q2 2018

Jul 18, 2018

BUY
$34.55 - $37.05 $13,819 - $14,819
400 Added 30.44%
1,714 $60,000
Q4 2017

Jan 24, 2018

SELL
$32.09 - $34.78 $19,157 - $20,763
-597 Reduced 31.24%
1,314 $45,000
Q3 2017

Oct 17, 2017

BUY
$28.96 - $34.0 $55,342 - $64,974
1,911
1,911 $65,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Tompkins Financial Corp Portfolio

Follow Tompkins Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.